Cogstate (ASX:CGS) YoY EPS Growth: 11.43% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:CGS Cogstate Ltd ASX:CGS
84 GF Score
Price A$2.59
GF Value A$2.10
Valuation Modestly Overvalued
View Full Analysis

What is Cogstate YoY EPS Growth?

Cogstate ASX:CGS -1.52% 84 YoY EPS Growth is 11.43% as of Dec. 2025. GuruFocus rates ASX:CGS with a GF Score™ of 84/100 and a GF Value™ of A$2.10 (Modestly Overvalued).

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Cogstate's YoY EPS Growth for the quarter that ended in Dec. 2025 was 11.43%.

Cogstate's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was A$0.04.

Cogstate YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Cogstate's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cogstate YoY EPS Growth Chart

Cogstate Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 433.33 50.00 -50.00 56.67 91.49

Cogstate Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,600.00 0.00 105.88 83.33 11.43
ASX:CGS
84GF Score
Cogstate Ltd ASX:CGS
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cogstate YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Cogstate's YoY EPS Growth for the fiscal year that ended in Jun. 2025 is calculated as:

YoY EPS Growth (A: Jun. 2025 )
=(Earnings per Share (Diluted) (A: Jun. 2025 )-Earnings per Share (Diluted) (A: Jun. 2024 ))/ | Earnings per Share (Diluted) (A: Jun. 2024 ) |
=(0.09-0.047)/ | 0.047 |
=91.49 %

Cogstate's YoY EPS Growth for the quarter that ended in Dec. 2025 is calculated as:

YoY EPS Growth (Q: Dec. 2025 )
=(Earnings per Share (Diluted) (Q: Dec. 2025 )-Earnings per Share (Diluted) (Q: Dec. 2024 )) / | Earnings per Share (Diluted) (Q: Dec. 2024 )) |
=(0.039-0.035)/ | 0.035 |
=11.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 11.43% mean?
Cogstate (ASX:CGS) has a YoY EPS Growth of 11.43% as of Dec. 2025. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Cogstate and its competitors.
Is Cogstate's YoY EPS Growth too high?
Cogstate's current YoY EPS Growth is 11.43%. Overall, Cogstate has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cogstate's YoY EPS Growth compare to VEEV and BTSG?
Cogstate's YoY EPS Growth of 11.43% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Healthcare Providers & Services company?
A good YoY EPS Growth depends on the Healthcare Providers & Services industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Cogstate and its competitors. Cogstate's current YoY EPS Growth is 11.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cogstate stock overvalued right now?
Based on GuruFocus' analysis, Cogstate (ASX:CGS) is currently considered Modestly Overvalued. The stock's GF Value™ is A$2.10, compared to a current price of A$2.59 — trading 23.3% above its estimated fair value. The current YoY EPS Growth is 11.43%. Cogstate's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Cogstate (ASX:CGS), the current YoY EPS Growth is 11.43% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cogstate (ASX:CGS) Overvalued in 2026?

Based on GuruFocus' analysis, Cogstate stock appears to be overvalued. The current stock price of A$2.59 is trading 23.3% above its estimated GF Value™ of A$2.10. GuruFocus considers Cogstate to be Modestly Overvalued.

Key valuation signals for ASX:CGS:

  • YoY EPS Growth: 11.43%
  • GF Value™: A$2.10 vs. price of A$2.59 (23.3% above fair value)
  • GF Score™: 84/100

No single metric tells the full story. See the ASX:CGS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cogstate Business Description

Other Exchanges COGZF:USAC4B:Germany
Address 367 Collins Street, Level 32, Melbourne, VIC, AUS, 3000
Cogstate Ltd is a cognitive science company. The principal activity of the group is the Creation, validation, and commercialisation of digital brain health assessments; and the Design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials, Healthcare, and Administration. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.
84GF Score

Get the complete analysis for ASX:CGS

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.59
Price
A$2.10
GF Value